Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi(Semmelweis University), Massimo Dominici(University of Modena and Reggio Emilia), Valeria Rasini(University of Modena and Reggio Emilia), Mara Tagliazzucchi(Semmelweis University), Franco Bambi(Meyer Children's Hospital), PierFranco Conte(University of Padua), Rita Bussolari(University of Modena and Reggio Emilia), Helga Barti-Juhász(Semmelweis University), Carlotta Spano(University of Modena and Reggio Emilia), Uliano Morandi(University of Modena and Reggio Emilia), Giulio Rossi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Edwin M. Horwitz(St. Jude Children's Research Hospital), István Peták(Semmelweis University), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Paolo Paolucci(University of Modena and Reggio Emilia), Giorgio De Santis, Christian Casali(University of Modena and Reggio Emilia), Laura Scarabelli(Semmelweis University), Luigi Cafarelli(Semmelweis University), Elena Veronesi(Semmelweis University)
Cited by 244
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|1k
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879